Scalper1 News
Prices for prescription skin drugs to treat everything from acne to skin cancer are skyrocketing, a report out Wednesday found, adding to the public debate about how much drugmakers ought to charge. A study published in JAMA Dermatology said that a survey of 19 brand-name prescription drugs, including those from Valeant Pharmaceuticals (VRX), GlaxoSmithKline (GSK) and Novartis (NVS), found their prices jumped 401% on average between 2009 and 2015. Scalper1 News
Scalper1 News